Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Surg Int ; 39(1): 21, 2022 Nov 30.
Article in English | MEDLINE | ID: mdl-36449115

ABSTRACT

PURPOSE: Total parenteral nutrition causes liver damage in patients with short bowel syndrome (SBS), in whom intestinal failure-associated liver disease (IFALD) is the strongest risk factor for mortality. We previously demonstrated the efficacy of dipeptidyl peptidase-4 inhibitors (DPP4-Is) for nutritional absorption and intestinal barrier function enhancement. Herein, we investigated the efficacy of DPP4-Is in preventing liver damage in SBS rat models. METHODS: Rats were allocated to one of five groups: normal saline (NS) + sham, DPP4-I + sham, NS + SBS, DPP4-I + SBS, and GLP-2 + SBS. DPP4-I or NS was administered orally once daily. Serum aspartate aminotransferase, alanine aminotransferase (ALT), alkaline phosphatase, and total bile acid levels were measured to assess liver function. Moreover, we evaluated liver damage using the SAF (steatosis activity fibrosis) score, which is also used to assess nonalcoholic steatohepatitis. RESULTS: ALT levels and SAF scores were significantly lower in the DPP4-I + SBS group than in the NS + SBS group. Jejunal and ileal villus heights were significantly higher in the DPP4-I + SBS group than in the GLP-2 + SBS group. CONCLUSIONS: The downregulation of ALT levels and SAF scores triggered by DPP4-I use may be correlated with DPP4-I-induced adiposis inhibition in SBS and NASH models. Therefore, DPP4-I may be used to reduce IFALD in patients with SBS.


Subject(s)
Dipeptidyl-Peptidase IV Inhibitors , Liver Failure , Non-alcoholic Fatty Liver Disease , Short Bowel Syndrome , Rats , Animals , Short Bowel Syndrome/complications , Short Bowel Syndrome/drug therapy , Dipeptidyl Peptidase 4 , Glucagon-Like Peptide 2 , Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use
2.
Int J Mol Sci ; 19(11)2018 Nov 19.
Article in English | MEDLINE | ID: mdl-30463256

ABSTRACT

Microsomal prostaglandin E synthetase-1 (mPGES-1) is an inducible terminal enzyme for the production of prostaglandin E2 (PGE2). In experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, mPGES-1 is induced in vascular endothelial cells (VECs) around inflammatory foci and facilitates inflammation, demyelination, and paralysis. Therefore, we investigated the role of CD31-positive VECs in mPGES-1-mediated EAE aggravation using immunohistochemical analysis and imaging of wild-type (wt) and mPGES-1-deficient (mPGES-1-/-) mice. We demonstrated that EAE induction facilitated vascularity in inflammatory lesions in the spinal cord, and this was significantly higher in wt mice than in mPGES-1-/- mice. In addition, endothelial interleukin-1ß (IL-1ß) production was significantly higher in wt mice than in mPGES-1-/- mice. Moreover, endothelial PGE2 receptors (E-prostanoid (EP) receptors EP1⁻4) were expressed after EAE induction, and IL-1ß was induced in EP receptor-positive VECs. Furthermore, IL-1 receptor 1 expression on VECs was increased upon EAE induction. Thus, increased vascularity is one mechanism involved in EAE aggravation induced by mPGES-1. Furthermore, mPGES-1 facilitated the autocrine function of VECs upon EP receptor induction and IL-1ß production, modulating mPGES-1 induction in EAE.


Subject(s)
Disease Progression , Encephalomyelitis, Autoimmune, Experimental/enzymology , Encephalomyelitis, Autoimmune, Experimental/pathology , Endothelial Cells/enzymology , Interleukin-1beta/metabolism , Microsomes/enzymology , Prostaglandin-E Synthases/metabolism , Up-Regulation , Animals , Demyelinating Diseases/pathology , Disease Models, Animal , Female , Mice, Inbred C57BL , Models, Biological , Paralysis/pathology , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Receptors, Interleukin-1/metabolism , Receptors, Prostaglandin E/metabolism , Spinal Cord/pathology
3.
Int J Mol Sci ; 18(12)2017 Dec 19.
Article in English | MEDLINE | ID: mdl-29257087

ABSTRACT

Microsomal prostaglandin synthetase-1 (mPGES-1) is an inducible terminal enzyme that produces prostaglandin E2 (PGE2). In our previous study, we investigated the role of mPGES-1 in the inflammation and demyelination observed in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, using mPGES-1-deficient (mPGES-1-/-) and wild-type (wt) mice. We found that mPGES-1 facilitated inflammation, demyelination, and paralysis and was induced in vascular endothelial cells and macrophages and microglia around inflammatory foci. Here, we investigated the role of interleukin-1ß (IL-1ß) in the intercellular mechanism stimulated by mPGES-1 in EAE spinal cords in the presence of inflammation. We found that the area invaded by CD4-positive (CD4⁺) T cells was extensive, and that PGE2 receptors EP1-4 were more induced in activated CD4⁺ T cells of wt mice than in those of mPGES-1-/- mice. Moreover, IL-1ß and IL-1 receptor 1 (IL-1r1) were produced by 65% and 48% of CD4⁺ T cells in wt mice and by 44% and 27% of CD4⁺ T cells in mPGES-1-/- mice. Furthermore, interleukin-17 (IL-17) was released from the activated CD4⁺ T cells. Therefore, mPGES-1 stimulates an intercellular interaction between CD4⁺ T cells by upregulating the autocrine function of IL-1ß in activated CD4⁺ T cells, which release IL-17 to facilitate axonal and myelin damage in EAE mice.


Subject(s)
Autocrine Communication , CD4-Positive T-Lymphocytes/metabolism , Encephalomyelitis, Autoimmune, Experimental/metabolism , Prostaglandin-E Synthases/metabolism , Animals , Female , Interleukin-1beta/metabolism , Mice , Mice, Inbred C57BL , Myelin Sheath/metabolism , Prostaglandin-E Synthases/genetics , Receptors, Interleukin-1 Type I/metabolism
4.
Front Behav Neurosci ; 11: 202, 2017.
Article in English | MEDLINE | ID: mdl-29123474

ABSTRACT

The proinflammatory cytokine interleukin-1 (IL-1) is produced by many types of cells, including immune cells in the periphery and glia and neurons in the brain. The type I IL-1 receptor (IL-1r1) is primarily responsible for transmitting the inflammatory effects of IL-1 and mediates several biological functions by binding to either IL-1α or IL-1ß. IL-1ß activation is associated with hippocampus-dependent memory tasks. Although IL-1ß impairs spatial memory under certain pathophysiological conditions, IL-1ß may be required for the normal physiological regulation of hippocampal plasticity and memory. In addition, brain IL-1ß levels are thought to change in the hippocampus in an age-dependent manner. These findings suggest that IL-1ß may have a beneficial, temporary effect on learning and memory in young mice, but the matter remains unclear. Therefore, we hypothesized that hippocampal IL-1ß has a beneficial effect on spatial learning and memory in young mice via IL-1r1, which is diminished in adults. We investigated the performance of young (3-month-old) and adult (6-month-old) wild-type mice, IL-1ß knockout mice (IL-1ßko) and IL-1r1 knockout mice (IL-1r1ko) in learning a spatial memory task with a fixed platform in a water maze (WM) and measured the levels of IL-1ß and IL-1α in the hippocampus and cortex of adult and young mice by using homogeneous time-resolved fluorescence (HTRF). Learning was significantly impaired in the training trials of the WM spatial memory task in young IL-1ßko and IL-1r1ko mice but not in adult IL-1ßko and IL-1r1ko mice. Moreover, young IL-1r1ko mice but not IL-1ßko mice showed an impairment in long-term memory extinction, suggesting that IL-1α might facilitate memory extinction. In this study, the cytokine assay using HTRF did not indicate a higher expression of hippocampal IL-1 in young mice but cortical IL-1ß and IL-1α were significantly increased in adult mice. We need to investigate the role of cortical IL-1 and the local IL-1 expression in the hippocampal neurons in the future.

SELECTION OF CITATIONS
SEARCH DETAIL
...